Supplement recall · August 15, 2018
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules recall
Why: Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case
- Lots / codes
Lot # 6E436-0; Product Code # 07596; Expiry Date: 09/2018
- Quantity
- 4,226 bottles (1691 Canada and 2535 USA)
- Company
- Seroyal International, a division of Atrium Innovations, Richmond Hill, Ontario
- Distribution
- Product was distributed throughout the United States and Canada (see attached document for list of Canadian consignees).
- Initiated
- July 27, 2018 · Voluntary: Firm initiated
- Classified
- August 6, 2018
- Reported
- August 15, 2018
- Ended
- November 25, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Niacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.